Boltwood Capital Management Gsk PLC Transaction History

Boltwood Capital Management

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 07, 2022	SELL	$42.05 - $47.77 $357,677 - $406,331	-8,506 Closed	0 $0
Q1 2022 Apr 20, 2022	BUY	$40.23 - $47.74 $563 - $668	14 Added 0.16%	8,506 $371,000
Q4 2021 Jan 10, 2022	SELL	$38.88 - $45.31 $3,149 - $3,670	-81 Reduced 0.94%	8,492 $374,000
Q3 2021 Oct 08, 2021	BUY	$38.79 - $43.16 $28,820 - $32,067	743 Added 9.49%	8,573 $328,000
Q2 2021 Jul 06, 2021	BUY	$36.52 - $41.46 $21,218 - $24,088	581 Added 8.01%	7,830 $312,000
Q1 2021 Apr 05, 2021	BUY	$34.27 - $40.01 $41,329 - $48,252	1,206 Added 19.96%	7,249 $259,000
Q4 2020 Jan 04, 2021	SELL	$34.07 - $39.94 $483,385 - $566,668	-14,188 Reduced 70.13%	6,043 $222,000
Q3 2020 Oct 05, 2020	BUY	$38.11 - $42.99 $9,527 - $10,747	250 Added 1.25%	20,231 $761,000
Q2 2020 Jul 02, 2020	BUY	$37.87 - $43.58 $13,860 - $15,950	366 Added 1.87%	19,981 $815,000
Q1 2020 Apr 07, 2020	BUY	$32.47 - $48.83 $636,899 - $957,800	19,615 New	19,615 $743,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $67.8B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Boltwood Capital Management, based on Form 13F filings with the SEC.

Stay updated on Boltwood Capital Management with notifications on news.